Vireo Growth (VREOF) Asset Writedowns and Impairment (2022 - 2026)

Vireo Growth's (VREOF) quarterly Asset Writedowns and Impairment came in at $100000.0 in Q1 2026, down 75.0% year-on-year from $400000.0 in Q1 2025, and down 84.76% quarter-over-quarter from $655969.0 in Q4 2025.

Vireo Growth (VREOF) Asset Writedowns and Impairment (2022 - 2026) Analysis & Trends

Vireo Growth has disclosed Asset Writedowns and Impairment across 4 years of filings, most recently posting $100000.0 for Q1 2026.

  • Asset Writedowns and Impairment for Q1 2026 came in at $100000.0, down 75.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 million (up 62.05% YoY), and the FY2025 annual result was $1.9 million, up 681.64% from the prior year.
  • Asset Writedowns and Impairment came in at $100000.0 for Q1 2026 at Vireo Growth, down from $655969.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $5.3 million in Q1 2022 to a low of -$304000.0 in Q1 2024.
  • The 4-year median for Asset Writedowns and Impairment is $393000.0 (2024), against an average of $827721.5.
  • Peak annual rise in Asset Writedowns and Impairment reached 508.09% in 2025, while the deepest fall reached 651.58% in 2025.
  • Vireo Growth's Asset Writedowns and Impairment stood at $1.1 million in 2022, then sank by 90.36% to $107873.0 in 2024, then jumped by 508.09% to $655969.0 in 2025, then tumbled by 84.76% to $100000.0 in 2026.
  • The last three Asset Writedowns and Impairment figures came in at $100000.0 (Q1 2026), $655969.0 (Q4 2025), and $996485.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Vireo Growth - - 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 100,000.00
Mar 31, 2026 100,000.00
Dec 31, 2025 655,969.00
Dec 31, 2025 655,969.00
Sep 30, 2025 996,485.00
Sep 30, 2025 996,485.00
Jun 30, 2025 -226,149.00
Jun 30, 2025 -226,149.00
Mar 31, 2025 400,000.00
Mar 31, 2025 400,000.00
Dec 31, 2024 107,873.00
Dec 31, 2024 107,873.00
Sep 30, 2024 393,000.00
Sep 30, 2024 393,000.00
Jun 30, 2024 41,000.00
Jun 30, 2024 41,000.00
Mar 31, 2024 -304,000.00
Mar 31, 2024 -304,000.00
Dec 31, 2022 1.12 Mn
Dec 31, 2022 1.12 Mn